Concepedia

Suki Klair

SK

Statistics

Publications

4

Citations

148

H-Index

4

Active since

2009

Affiliations

Institute of Cancer Research(Current)

Cancer Research UK

Suki Klair is an author at Institute of Cancer Research specializing in medicinal chemistry, drug discovery, and drug design.

Publications per year

2009–2015

4

Publications

4

Structure-Guided Evolution of Potent and Selective CHK1 Inhibitors through Scaffold Morphing

John Reader, Thomas P. Matthews, Suki Klair et al. · Journal of Medicinal Chemistry · 2011 · 60 citations · Full text

, , +17

Identification of Inhibitors of Checkpoint Kinase 1 through Template Screening

Thomas P. Matthews, Suki Klair, Samantha Burns et al. · Journal of Medicinal Chemistry · 2009 · 41 citations · Full text

, , +15

Design and evaluation of 3,6-di(hetero)aryl imidazo[1,2-a]pyrazines as inhibitors of checkpoint and other kinases

Thomas P. Matthews, Tatiana McHardy, Suki Klair et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 29 citations · Full text

, , +12

Discovery of HTL6641, a dual orexin receptor antagonist with differentiated pharmacodynamic properties

J.A. Christopher, Sarah J. Aves, Jason Brown et al. · MedChemComm · 2015 · 18 citations

, , +9

1–4 of 4